<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01018472</url>
  </required_header>
  <id_info>
    <org_study_id>200917427</org_study_id>
    <nct_id>NCT01018472</nct_id>
  </id_info>
  <brief_title>Probiotics in Infants With Cyanotic Congenital Heart Disease</brief_title>
  <official_title>Probiotics in Infants With Cyanotic Congenital Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Infants with congenital heart disease have more frequent infections and exposures to
      antibiotics than healthy infants. It is unknown how congenital heart disease affects the
      development of bacterial colonization of the intestines. It is also unknown whether
      probiotics will change the bacteria in the intestine of infants with heart disease to become
      more like those of healthy infants without heart disease. This pilot trial is designed to
      address these two questions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Infants with cyanotic congenital heart disease will be randomly assigned to receive either a
      placebo or probiotic Bifidobacterium infantis. Comparisons will be made between the infants
      receiving the placebo and healthy infants without heart disease and between the infants
      receiving the placebo and those receiving the probiotic.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fecal microbiota</measure>
    <time_frame>Weekly for 4 weeks then monthly</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Cyanotic Congenital Heart Disease</condition>
  <arm_group>
    <arm_group_label>Bifidobacterium infantis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Bifidobacterium infantis</intervention_name>
    <description>1 billion organisms twice daily either through a feeding tube or by mouth for 4 months</description>
    <arm_group_label>Bifidobacterium infantis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>A dilute preparation of pregestimil formula (similar in appearance to the probiotic product)</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cyanotic congenital heart disease

          -  Term infant

          -  Born at or transferred to UC Davis Children's hospital

        Exclusion Criteria:

          -  Congenital anomalies of the intestinal tract
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>4 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark A. Underwood, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UC Davis School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UC Davis Children's Hospital</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2009</study_first_submitted>
  <study_first_submitted_qc>November 19, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 23, 2009</study_first_posted>
  <last_update_submitted>December 1, 2014</last_update_submitted>
  <last_update_submitted_qc>December 1, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cyanotic heart disease</keyword>
  <keyword>congenital heart disease</keyword>
  <keyword>intestinal microbiota</keyword>
  <keyword>probiotics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

